{"id":"NCT01797094","sponsor":"Allergan","briefTitle":"BOTOX速 in the Treatment of Upper Facial Lines in Japan","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-02","primaryCompletion":"2013-07","completion":"2014-07","firstPosted":"2013-02-22","resultsPosted":"2015-02-10","lastUpdate":"2015-02-10"},"enrollment":101,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Upper Facial Rhytides","Crow's Feet Lines","Glabellar Lines","Frown Lines"],"interventions":[{"type":"BIOLOGICAL","name":"botulinum toxin Type A (44U)","otherNames":["BOTOX速"]},{"type":"BIOLOGICAL","name":"botulinum toxin Type A (32U)","otherNames":["BOTOX速"]}],"arms":[{"label":"Botulinum toxin Type A (44U)","type":"EXPERIMENTAL"},{"label":"Botulinum toxin Type A (32U)","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the safety and efficacy of BOTOX速 (botulinum toxin Type A) for the treatment of upper facial lines (Crow's Feet Lines and Frown Lines).","primaryOutcome":{"measure":"Percentage of Participants Achieving None or Mild on the Investigator's Assessment of the Severity of Crow's Feet Lines (CFL) at Maximum Smile Using the Facial Wrinkle Scale-Asian (FWS-A)","timeFrame":"Day 30","effectByArm":[{"arm":"Botulinum Toxin Type A (44U)","deltaMin":89.6,"sd":null},{"arm":"Botulinum Toxin Type A (32U)","deltaMin":84.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":6},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":47},"commonTop":["Injection site haemorrhage","Nasopharyngitis","Eczema","Eyelid ptosis","Pharyngitis"]}}